Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ira Pastan

Showing results (61-70 of 340) with videos related to

Pageof 34
Sort By:
Scientific Reports|June 27, 2015
Quantification of recombinant immunotoxin delivery to solid tumors allows for direct comparison of in vivo and in vitro resultsEmily Mason-Osann, Kevin Hollevoet, Gerhard Niederfellner, et al.
Cancer Research|August 5, 2008
Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activityXing Du, Richard Beers, David J Fitzgerald, et al.
Plos One|October 25, 2014
Effect of antigen shedding on targeted delivery of immunotoxins in solid tumors from a mathematical modelYoungshang Pak, Ira Pastan, Robert J Kreitman, et al.
Leukemia & Lymphoma|April 21, 2011
Immunotoxins with decreased immunogenicity and improved activityIra Pastan, Masanori Onda, John Weldon, et al.
Clinical & Developmental Immunology|March 9, 2012
Toxin-based targeted therapy for malignant brain tumorsVidyalakshmi Chandramohan, John H Sampson, Ira Pastan, et al.
Annual Review of Medicine|October 25, 2006
Immunotoxin treatment of cancerIra Pastan, Raffit Hassan, David J FitzGerald, et al.
Molecular Cancer Therapeutics|October 23, 2013
Antitumor effects of immunotoxins are enhanced by lowering HCK or treatment with SRC kinase inhibitorsXiu-Fen Liu, Laiman Xiang, David J FitzGerald, et al.
Oncotarget|July 16, 2016
Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapyChunguang Wang, Wei Gao, Mingqian Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2003
Impairment of reward-related learning by cholinergic cell ablation in the striatumYasuji Kitabatake, Takatoshi Hikida, Dai Watanabe, et al.
Cancer Research|July 22, 2011
Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin sheddingYujian Zhang, Oleg Chertov, Jingli Zhang, et al.
Pageof 34

Showing results (61-70 of 340) with videos related to

Sort By:
Pageof 34
Scientific Reports|June 27, 2015
Quantification of recombinant immunotoxin delivery to solid tumors allows for direct comparison of in vivo and in vitro resultsEmily Mason-Osann, Kevin Hollevoet, Gerhard Niederfellner, et al.
Cancer Research|August 5, 2008
Differential cellular internalization of anti-CD19 and -CD22 immunotoxins results in different cytotoxic activityXing Du, Richard Beers, David J Fitzgerald, et al.
Plos One|October 25, 2014
Effect of antigen shedding on targeted delivery of immunotoxins in solid tumors from a mathematical modelYoungshang Pak, Ira Pastan, Robert J Kreitman, et al.
Leukemia & Lymphoma|April 21, 2011
Immunotoxins with decreased immunogenicity and improved activityIra Pastan, Masanori Onda, John Weldon, et al.
Clinical & Developmental Immunology|March 9, 2012
Toxin-based targeted therapy for malignant brain tumorsVidyalakshmi Chandramohan, John H Sampson, Ira Pastan, et al.
Annual Review of Medicine|October 25, 2006
Immunotoxin treatment of cancerIra Pastan, Raffit Hassan, David J FitzGerald, et al.
Molecular Cancer Therapeutics|October 23, 2013
Antitumor effects of immunotoxins are enhanced by lowering HCK or treatment with SRC kinase inhibitorsXiu-Fen Liu, Laiman Xiang, David J FitzGerald, et al.
Oncotarget|July 16, 2016
Construction of an immunotoxin, HN3-mPE24, targeting glypican-3 for liver cancer therapyChunguang Wang, Wei Gao, Mingqian Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2003
Impairment of reward-related learning by cholinergic cell ablation in the striatumYasuji Kitabatake, Takatoshi Hikida, Dai Watanabe, et al.
Cancer Research|July 22, 2011
Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin sheddingYujian Zhang, Oleg Chertov, Jingli Zhang, et al.
Pageof 34